HEMODADRE: Intraoperative Hemodynamic Instability During Unilateral Adrenalectomy for Pheochromocytoma

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Recruiting
CT.gov ID
NCT06062082
Collaborator
(none)
60
1
108
0.6

Study Details

Study Description

Brief Summary

Pheochromocytomas are tumors of the adrenal gland that develop from cells producing adrenaline and noradrenaline. Consequently, intraoperative blood pressure variations (hypertensive and hypotensive episodes) are characteristic of pheochromocytoma surgery, when these tumors are removed. However, recommendations for the management of these tumors are based on data essentially dating from the 1960s-1990s. Since then, anesthesia and surgery for patients with pheochromocytoma have evolved considerably, and have become more effective with time. In these circumstances, a review of the current situation is necessary. The aim of this study is to investigate the intraoperative hemodynamic changes observed in patients undergoing adrenalectomy for pheochromocytoma, comparing them with the hemodynamic profile observed in patients undergoing adrenal surgery for a pathology other than pheochromocytoma (control group).

Condition or Disease Intervention/Treatment Phase
  • Procedure: adrenalectomy

Detailed Description

Each patient included in this study underwent unilateral adrenalectomy for adrenal pathology during the inclusion period. For each patient included, intraoperative hemodynamic data were collected every 20 seconds by the monitoring system used by the anesthesia team (VitalSignsCapture v1.004 program via RS232 port). For each patient, the HI score (a clinical tool validated in two previously published articles) was calculated for the intraoperative period (time between induction of anesthesia and patient discharge from the operating room). This enabled a comparison to be made between patients operated on for pheochromocytoma (30 patients) and patients operated on for a cause other than pheochromocytoma (30 patients).

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
What is Intraoperative Hemodynamic Instability During Unilateral Adrenalectomy for Pheochromocytoma: an Observational Study
Actual Study Start Date :
Sep 1, 2015
Anticipated Primary Completion Date :
Sep 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Pheochromocytoma

Patients operated on for pheochromocytoma by unilateral adrenalectomy

Procedure: adrenalectomy
laparoscopic exeresis of the adrenal gland

Control

Patients operated on for adrenal tumor other than pheochromocytoma by unilateral adrenalectomy

Procedure: adrenalectomy
laparoscopic exeresis of the adrenal gland

Outcome Measures

Primary Outcome Measures

  1. Hemodynamic instability score [during surgery (from induction of the patient under general anesthesia to discharge from the operating room)]

    The haemodynamic instability score was calculated as a weighted continuous measure ranging from 0 to 160 points. This score appropriately quantifies deviations of blood pressure and heart rate from predefined thresholds, and infusion rates of vasoactive agents and fluids. Zero corresponds to the absence of peroperative hemodynamic changes and 160 to the maximum possible peroperative hemodynamic changes.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients operated on for unilateral adrenal pathology by laparosocopic approach (pheochromocytoma and non-pheochromocytoma)
Exclusion Criteria:
  • Patients operated on for unilateral adrenal pathology by laparosocopic approach (pheochromocytoma and non-pheochromocytoma)

  • Patients operated on for bilateral adrenal pathology

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHRU Nancy - Département Chirurgie Viscérale, Métabolique et Cancérologique CVMC (7ème étage) Nancy France 54511

Sponsors and Collaborators

  • Central Hospital, Nancy, France

Investigators

  • Principal Investigator: Laurent Brunaud, CHU Nancy, Department CVMC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Laurent BRUNAUD, Principal investigator, Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT06062082
Other Study ID Numbers:
  • reference 2020PI123
First Posted:
Oct 2, 2023
Last Update Posted:
Oct 2, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Laurent BRUNAUD, Principal investigator, Central Hospital, Nancy, France
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 2, 2023